Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
about
PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouseDopamine supersensitivity correlates with D2High states, implying many paths to psychosisThe Involvement of Norepinephrine in Behaviors Related to Psychostimulant AddictionHuman Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout MiceChronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in miceβ1-Adrenergic receptors activate two distinct signaling pathways in striatal neuronsThe zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex.Norepinephrine loss produces more profound motor deficits than MPTP treatment in miceAbnormalities in brain structure and behavior in GSK-3alpha mutant miceBehavioral genetic contributions to the study of addiction-related amphetamine effects.A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosisBehavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapseAlpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand binding.Dopamine beta hydroxylase genotype identifies individuals less susceptible to bias in computer-assisted decision makingThere and back again: a tale of norepinephrine and drug addiction.Chronic stress, drug use, and vulnerability to addiction.Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbensElectrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouseα-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission.Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylaseSelective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 miceAlpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged accessNorepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety.Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action.Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrainDifferential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys.Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviorsThe role of the central noradrenergic system in behavioral inhibition.The effects of locus coeruleus and norepinephrine in methamphetamine toxicity.Dopamine transporter inhibition is required for cocaine-induced stereotypy.Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade.Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.Candidate system analysis in ADHD: Evaluation of nine genes involved in dopaminergic neurotransmission identifies association withDRD1
P2860
Q21135297-323CBF69-B413-4E80-B35D-8F1B146F3655Q24556648-35C3D109-AF16-488E-90E6-1B1D063BF3F7Q26786261-4A4789DC-3B3E-4CFC-885C-458FCEC153E1Q28115881-667DAD3E-8E51-41F0-822A-678969C2B505Q28485338-BF6B6803-B32A-4779-A93D-542DD76738B3Q28581364-50E0C3DC-E0E1-43F7-803D-68F014D86DFDQ28769152-F23C006D-CEC7-43B1-8025-9A1240E8BD02Q30241067-ECE3690A-B175-4F07-B794-A981BC030AC3Q30405046-E4EF0527-0144-4888-8628-BBC131548BB7Q30479999-E3085183-8231-4B7D-9963-F70DDD88D52BQ30485018-C97410C8-ACC1-48AA-B7ED-01065D6B18B6Q30494693-3C915C02-3060-4C1C-8C8D-EAA72E156D6CQ30572456-D8C2D219-43F8-49E6-8D9A-FB28C84A8200Q33678859-FD46A9C3-9A51-4C66-A4CE-F121A3DEE20EQ33819245-4A09F6F3-D22D-4992-A13E-9E1854F76E43Q33893155-424288D1-A63A-49BB-82C2-07F46A78A4E8Q33949566-6A961E99-B1B7-43C8-B65C-EF17C65F6A01Q34326431-7E87FCD3-6904-4683-9F22-5A7DC60B4E23Q34590409-55AA58CA-21B9-446D-819D-9E98D4846CA6Q34875333-865C0692-EF1D-4596-9F1B-1DBBE0E2B027Q35079713-82719EF2-AE06-46A6-A198-495D2FD3F1CAQ35741014-2035F8B0-BCB8-45CC-9B22-4AD439BD09EBQ36100281-1B839656-61FE-45D5-A1EA-5ACC6A3522A0Q36446037-1CAE7511-497C-4C0D-AE68-C7F4B968232DQ36462902-54B289DB-C8D0-4556-94FC-B765461D5220Q36645946-778709B2-965E-4412-B44F-845993065935Q36688691-F39F0C7C-4A4C-4C2F-B7BA-8752DABC097CQ37003897-50BC26B6-F6BB-49A1-B854-C0592C0B8DE5Q37029888-FCB7F3DA-2CF5-4622-82C2-F9C0B40FA91CQ37217480-63469268-50F1-4E74-A26D-2727E7AFE525Q37281980-B7CBA1F6-AAB4-4F6F-8DA9-D427DDD71B0CQ37663376-6B24CA1B-2D7A-4C92-8595-B4FC54BE6EDAQ37840475-114A286A-22B0-4D30-BC25-D1CEAB1CFC45Q38118305-8CB8E3A5-41AB-433F-863A-9A7B6C4A6233Q39321610-442A995C-9571-4803-8565-60D754616AD9Q44811420-2961CBC0-4890-415A-8626-EDDF4502828AQ46202403-1C49E6B2-D46C-4F49-B19B-DEEE52F6F294Q52307553-3EDCA06D-F96C-48A6-8BE4-24B6235EA729Q58408125-131A5A0E-0EB5-494C-8B2C-73DB1B703A13
P2860
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@ast
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@en
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@nl
type
label
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@ast
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@en
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@nl
prefLabel
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@ast
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@en
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@nl
P2093
P2860
P3181
P356
P1476
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
@en
P2093
David Weinshenker
Katherine Blizinsky
Marc L Laughlin
Nicole S Miller
Richard D Palmiter
P2860
P304
13873-13877
P3181
P356
10.1073/PNAS.212519999
P407
P577
2002-10-07T00:00:00Z